Annual EBITDA
-$741.79M$365.63M-97.20%
Summary
- Current Value
- As of today, RNA annual EBITDA is -$741.79M, down -97.20% on
- Historical Performance
- RNA annual EBITDA is down -317.85% over the past 3 years, down -1589.58% over the past 5 years
- All-Time High Comparison
- RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on
- 3-Year Low Comparison
- RNA annual EBITDA is at its 3-year low
- Sector Comparison
- RNA annual EBITDA is higher than 0.77% of companies in Healthcare sector
EBITDA Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual EBITDA | -$741.79M | -97.2% | -317.9% | -1589.6% | -7233.6% | |
| Quarterly EBITDA | -$17.13M | -131.5% | +69.7% | +27.9% | -748.0% | |
| TTM EBITDA | -$46.11M | +76.1% | +76.9% | +25.2% | -2182.6% | |
| Price | $12.72 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Annual Revenue | $18.62M | +70.8% | +101.8% | +174.3% | +4812.4% | |
| Annual EPS | -$2.89 | -97.0% | +13.3% | -41.3% | -867.4% | |
| -$745.94M | -96.8% | -316.9% | -1584.7% | -7005.6% | ||
| Annual Net Income | -$49.50M | -97.0% | +71.5% | -11.6% | -341.3% |
EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | -$177.53M | N/A | -317.9% |
| 5Y | -$43.90M | N/A | -1589.6% |
| All | -$10.12M | -7233.6% |
EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | -$741.79M | at low | |
| 5Y | -$741.79M | at low | |
| All | -$741.79M | at low |
EBITDA History
| Year | Value | Change |
|---|---|---|
| -$741.79M | -97.2% | |
| -$376.16M | -61.1% | |
| -$233.50M | -31.5% | |
| -$177.53M | -51.2% |
| Year | Value | Change |
|---|---|---|
| -$117.41M | -167.4% | |
| -$43.90M | -162.3% | |
| -$16.74M | -65.4% | |
| -$10.12M | - |
FAQ
What is the current annual EBITDA of RNA?
As of today, RNA annual EBITDA is -$741.79M
What is 1-year change in RNA annual EBITDA?
RNA annual EBITDA is down -97.20% year-over-year
What is 3-year change in RNA annual EBITDA?
RNA annual EBITDA is down -317.85% over the past 3 years
How far is RNA annual EBITDA from its all-time high?
RNA annual EBITDA is currently -7233.58% below its historical high of -$10.12M set on December 31, 2018
How does RNA annual EBITDA rank versus sector peers?
RNA annual EBITDA is higher than 0.77% of companies in Healthcare sector
When is RNA next annual earnings release?
As of today, the next annual earnings release for RNA has not been scheduled
Quarterly EBITDA
-$17.13M$11.85M+40.89%
Summary
- Current Value
- As of today, RNA quarterly EBITDA is -$17.13M, up +40.89% on
- Historical Performance
- RNA quarterly EBITDA is down -131.50% year-over-year, up +69.69% over the past 3 years
- All-Time High Comparison
- RNA quarterly EBITDA is currently -747.97% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA quarterly EBITDA is +82.42% above its 3-year low of -$97.42M reached on
- Sector Comparison
- RNA quarterly EBITDA is higher than 25.58% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly EBITDA | -$17.13M | +40.9% | -131.5% | +69.7% | +27.9% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| TTM EBITDA | -$46.11M | -26.8% | +76.1% | +76.9% | +25.2% | |
| Price | $12.72 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| Quarterly Revenue | $19.64M | +2185.8% | +1148.3% | +779.3% | +626.1% | |
| Quarterly EPS | -$0.97 | +42.9% | -123.3% | -30.7% | -53.0% | |
| -$17.28M | +40.6% | -131.9% | +70.0% | +27.6% | ||
| Quarterly Net Income | -$16.63M | +42.9% | -123.3% | +68.3% | +30.2% |
Quarterly EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$7.40M | N/A | -131.5% |
| 3Y | -$6.19M | -176.6% | |
| 5Y | -$6.19M | -176.6% | |
| All | -$2.02M | -748.0% |
Quarterly EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$28.98M | +40.9% | |
| 3Y | -$97.42M | +82.4% | |
| 5Y | -$97.42M | +82.4% | |
| All | -$97.42M | +82.4% |
Quarterly EBITDA History
FAQ
What is the current quarterly EBITDA of RNA?
As of today, RNA quarterly EBITDA is -$17.13M
What is RNA quarterly EBITDA most recent change?
RNA quarterly EBITDA was up +40.89% on March 31, 2026
What is 1-year change in RNA quarterly EBITDA?
RNA quarterly EBITDA is down -131.50% year-over-year
How far is RNA quarterly EBITDA from its all-time high?
RNA quarterly EBITDA is currently -747.97% below its historical high of -$2.02M set on March 31, 2019
How does RNA quarterly EBITDA rank versus sector peers?
RNA quarterly EBITDA is higher than 25.58% of companies in Healthcare sector
When is RNA next earnings release?
As of today, the next earnings release for RNA has not been scheduled
TTM EBITDA
-$46.11M$9.73M-26.75%
Summary
- Current Value
- As of today, RNA TTM EBITDA is -$46.11M, down -26.75% on
- Historical Performance
- RNA TTM EBITDA is up +76.10% year-over-year, up +76.93% over the past 3 years
- All-Time High Comparison
- RNA TTM EBITDA is currently -2182.62% below its historical high of -$2.02M set on
- 3-Year Low Comparison
- RNA TTM EBITDA is +85.68% above its 3-year low of -$322.04M reached on
- Sector Comparison
- RNA TTM EBITDA is higher than 30.38% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM EBITDA | -$46.11M | -26.8% | +76.1% | +76.9% | +25.2% | |
| Annual EBITDA | -$741.79M | – | -97.2% | -317.9% | -1589.6% | |
| Quarterly EBITDA | -$17.13M | +40.9% | -131.5% | +69.7% | +27.9% | |
| Price | $12.72 | – | – | – | – | |
| PE Ratio | - | – | – | – | – | |
| TTM Revenue | $20.49M | +742.7% | +129.6% | +112.1% | +152.0% | |
| TTM EPS | -$2.67 | -25.1% | -10.4% | +20.4% | -61.4% | |
| -$46.38M | -26.9% | +76.2% | +77.0% | +25.2% | ||
| TTM Net Income | -$45.77M | -25.1% | +73.1% | +76.2% | +26.3% |
TTM EBITDA Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | -$36.38M | -26.8% | |
| 3Y | -$36.38M | -26.8% | |
| 5Y | -$36.38M | -26.8% | |
| All | -$2.02M | -2182.6% |
TTM EBITDA Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | -$192.96M | N/A | +76.1% |
| 3Y | -$322.04M | +85.7% | |
| 5Y | -$322.04M | +85.7% | |
| All | -$322.04M | +85.7% |
TTM EBITDA History
FAQ
What is the current TTM EBITDA of RNA?
As of today, RNA TTM EBITDA is -$46.11M
What is RNA TTM EBITDA most recent change?
RNA TTM EBITDA was down -26.75% on March 31, 2026
What is 1-year change in RNA TTM EBITDA?
RNA TTM EBITDA is up +76.10% year-over-year
How far is RNA TTM EBITDA from its all-time high?
RNA TTM EBITDA is currently -2182.62% below its historical high of -$2.02M set on March 31, 2019
How does RNA TTM EBITDA rank versus sector peers?
RNA TTM EBITDA is higher than 30.38% of companies in Healthcare sector
When is RNA next earnings release?
As of today, the next earnings release for RNA has not been scheduled
EBITDA Formula
EBITDA = Net Income + + +
Data Sources & References
- RNA Official Website www.atriumtherapeutics.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1599901/000159990126000031/0001599901-26-000031-index.htm
- RNA Profile on Yahoo Finance finance.yahoo.com/quote/RNA
- RNA Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/rna